Free Trial

Dogwood Therapeutics (DWTX) Earnings Date, Estimates & Call Transcripts

Dogwood Therapeutics logo
$4.25 +0.07 (+1.67%)
Closing price 04:00 PM Eastern
Extended Trading
$4.11 -0.15 (-3.41%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dogwood Therapeutics Latest Earnings Summary

Latest Q4 2024
Earnings Date
Mar. 31Estimated
Actual EPS
(Mar. 31)
-$6.29 Missed By -$4.80
Consensus EPS
(Mar. 31)
-$1.49

Dogwood Therapeutics released Q4 2024 earnings on March 31, 2025, reporting an EPS of -$6.29, which missed analysts' consensus estimates of -$1.49 by $4.80. With a trailing EPS of -$11.34, Dogwood Therapeutics' earnings are expected to grow next year, from ($6.43) to ($4.57) per share.

Get Dogwood Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dogwood Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DWTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DWTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Dogwood Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($6.43) EPS
Next Year EPS Consensus Estimate: ($4.57) EPS
Remove Ads

Dogwood Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/31/2025Q4 2024-$1.49-$6.29 -$4.80-$6.29--
11/7/2024Q3 2024-$1.33-$2.05 -$0.72-$2.05--
8/8/2024Q2 2024-$1.75-$1.25+$0.50-$1.25--
5/9/2024Q1 2024-$2.00-$1.75+$0.25-$1.75--
2/29/2024Q4 2023-$2.25-$1.50+$0.75-$1.50--
11/13/2023Q3 2023-$2.50-$1.50+$1.00-$1.50--
8/10/2023Q2 2023-$1.75-$2.00 -$0.25-$2.00--
5/11/2023Q1 2023--$2.00 -$2.00-$2.00--

Dogwood Therapeutics Earnings - Frequently Asked Questions

Dogwood Therapeutics (NASDAQ:DWTX) last announced its quarterly earning data on Monday, March 31, 2025. Learn more on DWTX's earnings history.

In the previous quarter, Dogwood Therapeutics (NASDAQ:DWTX) missed the analysts' consensus estimate of ($1.49) by $4.80 with a reported earnings per share (EPS) of ($6.29). Learn more on analysts' earnings estimate vs. DWTX's actual earnings.

Dogwood Therapeutics (NASDAQ:DWTX) has a recorded net income of -$5.30 million. DWTX has generated -$11.34 earnings per share over the last four quarters.

Dogwood Therapeutics's earnings are expected to grow from ($6.43) per share to ($4.57) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:DWTX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners